GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 181 filers reported holding GW PHARMACEUTICALS PLC in Q3 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,504,000 | -71.7% | 15,000 | -62.5% | 0.85% | -10.2% |
| Q3 2016 | $5,310,000 | +26.0% | 40,000 | -34.1% | 0.95% | -31.7% |
| Q4 2015 | $4,214,000 | +15.3% | 60,687 | +51.7% | 1.39% | -3.5% |
| Q3 2015 | $3,655,000 | -33.9% | 40,000 | -11.1% | 1.44% | -17.6% |
| Q2 2015 | $5,528,000 | +21.3% | 45,000 | -10.0% | 1.74% | -9.0% |
| Q1 2015 | $4,557,000 | +12.2% | 50,000 | -16.7% | 1.92% | -2.3% |
| Q4 2014 | $4,061,000 | +0.4% | 60,000 | +20.0% | 1.96% | -9.1% |
| Q3 2014 | $4,043,000 | -11.3% | 50,000 | +17.6% | 2.16% | +1.6% |
| Q2 2014 | $4,560,000 | +207.3% | 42,500 | +70.0% | 2.13% | +210.1% |
| Q1 2014 | $1,484,000 | – | 25,000 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |